NO996514L - Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom - Google Patents

Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom

Info

Publication number
NO996514L
NO996514L NO996514A NO996514A NO996514L NO 996514 L NO996514 L NO 996514L NO 996514 A NO996514 A NO 996514A NO 996514 A NO996514 A NO 996514A NO 996514 L NO996514 L NO 996514L
Authority
NO
Norway
Prior art keywords
diagnosis
lyme disease
prevention
compositions
surface antigens
Prior art date
Application number
NO996514A
Other languages
English (en)
Norwegian (no)
Other versions
NO996514D0 (no
Inventor
Mario T Philipp
Original Assignee
Univ Tulane
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Tulane filed Critical Univ Tulane
Publication of NO996514D0 publication Critical patent/NO996514D0/no
Publication of NO996514L publication Critical patent/NO996514L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/20Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Spirochaetales (O), e.g. Treponema, Leptospira
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
NO996514A 1997-06-30 1999-12-28 Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom NO996514L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5127197P 1997-06-30 1997-06-30
PCT/US1998/013551 WO1999000413A1 (fr) 1997-06-30 1998-06-29 Antigenes de surface et proteines utiles dans des compositions utilisees pour le diagnostic et la prevention de la maladie de lyme

Publications (2)

Publication Number Publication Date
NO996514D0 NO996514D0 (no) 1999-12-28
NO996514L true NO996514L (no) 2000-02-14

Family

ID=21970280

Family Applications (1)

Application Number Title Priority Date Filing Date
NO996514A NO996514L (no) 1997-06-30 1999-12-28 Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom

Country Status (17)

Country Link
US (2) US6660274B2 (fr)
EP (1) EP1012181B1 (fr)
JP (1) JP2002511760A (fr)
KR (1) KR20010020567A (fr)
CN (1) CN1261896A (fr)
AR (1) AR016295A1 (fr)
AT (1) ATE337335T1 (fr)
AU (1) AU8177298A (fr)
CA (1) CA2294701C (fr)
CO (1) CO4790101A1 (fr)
DE (1) DE69835682T2 (fr)
DK (1) DK1012181T3 (fr)
ES (1) ES2270523T3 (fr)
NO (1) NO996514L (fr)
PL (1) PL337667A1 (fr)
WO (1) WO1999000413A1 (fr)
ZA (1) ZA985704B (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69733944T3 (de) 1996-02-21 2012-07-26 The Board Of Regents, The University Of Texas System Vmp-ähnliche sequenzen von pathogener borrelia
CA2294701C (fr) * 1997-06-30 2009-09-08 The Administrators Of The Tulane Educational Fund Antigenes de surface et proteines utiles dans des compositions utilisees pour le diagnostic et la prevention de la maladie de lyme
US6475492B1 (en) 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease
EP2292762A3 (fr) 2002-12-20 2012-12-12 Board of Regents, The University of Texas System Séquences d'espèces et de souches de Borrelia pathogène de type VMP
WO2007133623A2 (fr) * 2006-05-10 2007-11-22 Biopeptides Corporation Agent de diagnostic peptidique pour la maladie de lyme
EP2077856B1 (fr) * 2006-11-03 2015-08-12 Intervet International BV Vaccin contre la maladie de lyme canine
ES2337113B1 (es) * 2007-04-17 2011-01-24 Centre De Recerca En Sanitat Animal (Cresa) Empleo de la hemaglutinina del virus de la peste porcina africana como adyuvante.
WO2009033163A2 (fr) * 2007-09-07 2009-03-12 The Regents Of The University Of California Procédés de diagnostic et de criblage concernant borrelia
WO2010132758A2 (fr) * 2009-05-14 2010-11-18 Gomes-Solecki Maria J Test de diagnostic à base de ospc pour la maladie de lyme
CN102791727A (zh) 2009-11-17 2012-11-21 爱贝斯股份有限公司 用于检测莱姆病抗体的肽和方法
KR102222869B1 (ko) * 2010-05-14 2021-03-04 박스알타 인코퍼레이티드 키메라 ospa 유전자, 단백질 및 이의 사용 방법
CA2812759A1 (fr) 2010-09-27 2012-04-12 Cornell University Procedes de diagnostic de la maladie de lyme
US10100092B2 (en) 2011-11-03 2018-10-16 Vca, Inc. Compositions and methods to detect various infectious organisms
US8758772B2 (en) 2011-11-04 2014-06-24 Abaxis, Inc. Peptides and methods for the detection of lyme disease antibodies
US9670537B2 (en) 2014-06-06 2017-06-06 Titan Collaborative Kithe, Llc Borrelia Provocation Procedure kit
WO2016049148A1 (fr) 2014-09-24 2016-03-31 Wellstat Diagnostics, Llc Compositions et méthodes de diagnostic de la maladie de lyme
WO2017035389A1 (fr) 2015-08-27 2017-03-02 Quidel Corporation Dispositif d'analyse par dosage immunologique comportant deux trajets d'écoulement de fluide pour la détection et la différentiation d'au moins deux analytes
CN106432487A (zh) * 2016-10-31 2017-02-22 杭州贝英福生物科技有限公司 一种伽氏疏螺旋体多克隆抗体及应用
CN106397589A (zh) * 2016-10-31 2017-02-15 杭州贝英福生物科技有限公司 一种狭义伯氏疏螺旋体多克隆抗体及应用
JP2020507772A (ja) 2017-02-10 2020-03-12 クイデル コーポレーション 制御流体フロー用チャネルを有する基材を用いたラテラルフローアッセイ
CN109596824A (zh) * 2019-01-04 2019-04-09 杭州奥泰生物技术股份有限公司 一种快速诊断莱姆病的检测试纸及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US485551A (en) 1892-11-01 And william
DK590288D0 (da) * 1988-10-24 1988-10-24 Symbicom Ab Kemiske forbindelser
EP0339695A3 (fr) 1988-04-29 1990-05-30 Stichting Voor De Technische Wetenschappen Procédé de préparation d'un conjugué antigénique ou immunogénique ainsi que l'utilisation de tels conjugués
CA2072008C (fr) 1989-12-22 2003-01-28 Renate Fuchs Proteines a activite immunologique provenant de borrelia burgdorferi, trousses de dosage contenant ces proteines et permettant la detection d'anticorps dans des milieux liquides, et utilisation de ces proteines comme vaccins contre les infections causees par differentes souches de borrelia
US5217872A (en) * 1990-02-27 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Method for detection of borrelia burgdorferi antigens
DE69122240T2 (de) 1990-03-05 1997-02-13 The United States of America, represented by the Secretary, U.S. Department of Commerce, Washington, D.C. Antigen-wirkende proteine von borrelia burgdorferi
JPH06501382A (ja) 1990-06-15 1994-02-17 エール ユニバーシティ ライム病の予防および診断に用いる組成物および方法
EP1016416A3 (fr) * 1990-07-06 2002-10-23 Wyeth Vaccin contre la maladie de lyme et modèle pour l'évaluation de l'efficacité du vaccin
DE69733944T3 (de) * 1996-02-21 2012-07-26 The Board Of Regents, The University Of Texas System Vmp-ähnliche sequenzen von pathogener borrelia
DE19632862B4 (de) * 1996-08-14 2006-08-03 Mikrogen Molekularbiologische Entwicklungs-Gmbh Immunologisch aktive Proteine von Borrelia burgdorferi, dafür kodierende Nukleinsäuren sowie deren Verwendung in Testkits und als Impfstoffe
CA2294701C (fr) * 1997-06-30 2009-09-08 The Administrators Of The Tulane Educational Fund Antigenes de surface et proteines utiles dans des compositions utilisees pour le diagnostic et la prevention de la maladie de lyme
US6475492B1 (en) * 1999-04-28 2002-11-05 The Administrators Of The Tulane Educational Fund Peptides and assays for the diagnosis of lyme disease

Also Published As

Publication number Publication date
CA2294701C (fr) 2009-09-08
ZA985704B (en) 1999-01-13
AU8177298A (en) 1999-01-19
JP2002511760A (ja) 2002-04-16
PL337667A1 (en) 2000-08-28
US6660274B2 (en) 2003-12-09
DE69835682D1 (de) 2006-10-05
ATE337335T1 (de) 2006-09-15
CN1261896A (zh) 2000-08-02
AR016295A1 (es) 2001-07-04
WO1999000413A1 (fr) 1999-01-07
DK1012181T3 (da) 2007-01-02
NO996514D0 (no) 1999-12-28
DE69835682T2 (de) 2007-08-23
KR20010020567A (ko) 2001-03-15
US20030059894A1 (en) 2003-03-27
CA2294701A1 (fr) 1999-01-07
US20040067517A1 (en) 2004-04-08
EP1012181A1 (fr) 2000-06-28
ES2270523T3 (es) 2007-04-01
EP1012181B1 (fr) 2006-08-23
CO4790101A1 (es) 1999-05-31

Similar Documents

Publication Publication Date Title
NO996514L (no) Overflateantigener og proteiner nyttige i sammensetninger for diagnose og forebygging av Lymesykdom
CY1117387T1 (el) ΜΟΝΟΚΛΩΝΙΚΑ ΑΝΤΙΣΩΜΑΤΑ Ν-11 ΔΙΑΣΠΑΣΜΕΝΟΥ β-ΑΜΥΛΟΕΙΔΟΥΣ, ΣΥΝΘΕΣΕΙΣ, ΜΕΘΟΔΟΙ ΚΑΙ ΧΡΗΣΕΙΣ
BR9714160A (pt) Antìgenos uspa1 e uspa2 de moraxella catarrhalis
WO2005056600A3 (fr) Anticorps monoclonaux se liant ou neutralisant le virus de la dengue
ATE165395T1 (de) Inhibitoren des tumorwachstums aus geweben, methoden ihrer herstellung und verwendungen
WO2000077216A3 (fr) Vaccin poxvirus recombine contre le circovirus porcin
BR9610872A (pt) Proteìna receptora de transferrina de moraxella
SE0103754L (sv) Peptider från apolipoprotein B, användning därav immunisering, diagnosmetod eller terapeutisk behandling av ischemiska kardiovaskulära sjukdomar, samt farmaceutisk komposition och vaccin innehållande sådan peptid
ATE453403T1 (de) Wirtszelle enthaltend ein rekombinantes virus, welches ein antigen exprimiert und ein rekombinantes virus, welches ein immunstimulatorisches molekül exprimiert
EP1731166A3 (fr) Protéines et vaccins de streptococcus pneumoniae
WO2003083485A3 (fr) Proteine destinee a etre utilisee dans des etats lies a une hypoxie
AU2001276619A1 (en) Immunisation against chlamydia pneumoniae
EP0683234A4 (fr) ANTICORPS DIRIGE CONTRE LE -g(b)-AMYLOIDE OU UN DERIVE DE CE DERNIER ET SON UTILISATION.
EP0090581A3 (fr) Petits peptides specifiques des antigènes de la fièvre aphteuse
DE60036698D1 (de) Chlamydia-antigene und entsprechende dna-fragmente und deren verwendungen
ATE132197T1 (de) Monoklonale antikörper
NO331277B1 (no) Farmasoytisk sammensetning omfattende polypetid/nukleinsyre for behandling av retinale degenererende sykdommer, vektor, isolert polypeptid, renset antistoff og anvendelse av polypeptid, nukleinsyre og antistoff, samt fremgangsmater og kit
UA42040C2 (uk) Поліпептид, спосіб діагностики інсулінозалежного цукрового діабету (iddm), що розвинувся або що розвивається (варіанти), набір для діагностики iddm (варіанти), препарат для запобігання або лікування iddm, фармацевтична композиція для профілактики або лікування iddm
ATE142888T1 (de) Antigen-wirkende proteine von borrelia burgdorferi
DE69737323D1 (de) Adhesin aus heliobacter pylori, welches an blutgruppenantigene bindet
BR0207528A (pt) Anticorpo, composição farmacêutica, e, usos de uma quantidade efetiva de um agente, de uma quantidade terapeuticamente efetiva de um anticorpo para il-22, de uma quantidade imunogênica do antìgeno e uma quantidade aumentadora de imunogenicidade de il-22 em combinação, de uma quantidade efetiva do anticorpo ou fragmento do mesmo e de uma quantidade suficiente de anticorpo ou fragmento ligado a antìgeno do mesmo
DE69233311D1 (de) Weidelgraspollen-allergen
AU2002310474A1 (en) Multiple antigenic peptide displaying multiple copies of an epitope of plaque-forming polypeptide and methods of using same
PT868522E (pt) Virus recombinante de poxvirus - virus da peritonite infecciosa felina, suas composicoes e metodos para a sua preparacao e utilizacao
DE69738770D1 (de) Porphyromonas gingivalis Antigene zur Diagnose und Behandlung von Periodontitis

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application